Healthcare - Biotechnology - NASDAQ - US
$ 0.3353
0.119 %
$ 24.3 M
Market Cap
-0.45
P/E
CASH FLOW STATEMENT
-23.3 M
OPERATING CASH FLOW
-600 K
INVESTING CASH FLOW
27 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
IN8bio, Inc.
| Net Income | -30 M |
| Depreciation & Amortization | 2.5 M |
| Capital Expenditures | -600 K |
| Stock-Based Compensation | 4.37 M |
| Change in Working Capital | -204 K |
| Others | 777 K |
| Free Cash Flow | -23.9 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (30.0) | (28.5) | (14.7) | (8.6) | (5.1) | (2.1) |
| Depreciation & Amortization | 2.5 | 1.1 | 0.8 | 88 K | 96 K | 96 K |
| Deferred Income Tax | 0 | (4.2) | (0.5) | 0 | 0 | 0 |
| Stock Based Compensation | 4.4 | 3.5 | 2.2 | 0.4 | 76 K | 31 K |
| Other Operating Activities | 0 | 4.2 | 0.5 | 0.4 | 68 K | 70 K |
| Change in Working Capital | (0.2) | (0.2) | (1.8) | 0.6 | 93 K | (0.9) |
| Cash From Operations | (23.3) | (24.1) | (13.5) | (7.1) | (4.8) | (2.8) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (0.6) | (3.7) | (0.3) | 0 | (0.3) | (0.8) |
| Other Items | 0 | 0 | 0 | 0 | 0.7 | 0 |
| Cash From Investing Activities | (0.6) | (3.7) | (0.3) | 0 | 0.4 | (0.8) |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (0.8) | (0.6) | (0.7) | 0.2 | 0 | 1.3 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.3 | 61 K | (2.7) | 23.8 | 65 K | 14.5 |
| Cash From Financing Activities | 27.0 | 9.0 | 33.0 | 24.5 | 65 K | 8.5 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | 3.1 | (18.8) | 19.1 | 17.4 | (4.4) | 5.0 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (23.9) | (27.8) | (13.8) | (7.1) | (5.1) | (3.5) |